The North America advanced medical stopcock market is expected to grow from US$ 335.94 million in 2021 to US$ 430.56 million in 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028.
A stopcock is a ball valve that is used to control the flow of a liquid or gas in laboratories. These are available in different types, among which a three-way stopcock is made of polycarbonate and has numerous channels for multiple infusion therapy. It is mainly used in intensive therapy units (ITU) and all ward regions where intra-arterial and intra-venous systems are used during different procedures. The growth of the North America advanced medical stopcock market is attributed to the factors such as the growing incidence of chronic diseases and a surge in the number of surgical procedures. However, safety concerns regarding stopcocks are hindering the market growth.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
North America Advanced Medical Stopcock Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
North America Advanced Medical Stopcock Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Mexico Advanced Medical Stopcock Market Revenue and Forecast to 2028 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Market Insights
Growing Incidence of Chronic Diseases
According to the 2022 statistics of the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), six in ten Americans suffer from at least one chronic disease, such as heart disease, stroke, cancer, or diabetes. Additionally, as per the Canadian Chronic Disease Surveillance System, in 2018, 73% of individuals aged 65 or more suffered from at least one chronic disease. In addition, the severity of chronic diseases can be avoided by taking some measures at the initial stage of the diagnosis. The treatment for chronic diseases includes medication, intravenous therapies, or surgical procedures. Infusion therapy is often used in the treatment of many chronic diseases, such as heart failure, cancer, chronic lung diseases, stroke, diabetes, and chronic kidney disease. These treatments require infusion pumps, which is a medical device that consists of a stopcock. It is used to deliver fluids, such as nutrients and medications, including antibiotics, insulin or other hormones, chemotherapy drugs, and pain relievers, into a patient's body in precise amounts. Medical stopcocks are widely used in healthcare settings to deliver infusion therapy to patients of all ages. Moreover, according to the Centers for Disease Control and Prevention (CDC), in the US, in 2019, ~1,752,735 new cases of cancer were reported, and ~599,589 patients died of cancer. Additionally, as per the Globocan 2020, in 2020, there were ~195,499 new cases of cancer in Mexico, and ~90,222 people died due to cancer. Hence, advanced medical stopcocks are widely used during the procedure of chemotherapy to control the dosage of intravenous medicines. Thus, the increasing incidences of chronic diseases are driving the North America advanced medical stopcock market.
The rising number of COVID-19 patients led to a positive impact on the market. In 2021, the US FDA authorized an emergency use authorization (EUA) monoclonal antibody Intravenous (IV) therapy for COVID-19 patients suffering from mild to moderate symptoms. IV therapy administers medicines directly into the patient’s bloodstream with the help of stopcocks. Monoclonal antibodies block viral attachment and entry into human cells to neutralize SARS-CoV-2. Also, in November 2020, the FDA approved a EUA for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19. Also, IV vitamin drips were administered to COVID-19 patients for faster recovery. Thus, the growing number of FDA-approved infusion therapy and IV drips for the treatment of COVID-19 is supporting the North America advanced medical stopcock market.
Type-Based Insights
Based on type, the North America advanced medical stopcock market is segmented into low-pressure stopcocks, medium-pressure stopcocks, and high-pressure stopcocks. The low-pressure stopcocks segment held the largest share of the market in 2021, and it is expected to grow at a rapid rate during the forecast period.
North America Advanced Medical Stopcock Market, by Product – 2021 and 2028


- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
End User-Based Insights
Based on end user, the North America advanced medical stopcock market is segmented into hospitals & clinics, homecare, and ambulatory surgery centers. The hospitals & clinics segment held the largest share of the market in 2021, and it is expected to register the highest CAGR during the forecast period.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Various companies in the North America advanced medical stopcock market focus on the collaboration strategy to enlarge their clientele, which, in turn, helps them maintain their brand name across the world.
North America Advanced Medical Stopcock Market – by Type
- Low-Pressure Stopcocks
- Medium-Pressure Stopcocks
- High-Pressure Stopcocks
North America Advanced Medical Stopcock Market – by End User
- Hospitals & Clinics
- Ambulatory Surgical Centres
- Homecare
North America Advanced Medical Stopcock Market – by Country
- US
- Canada
- Mexico
Company Profiles
- B. Braun Melsungen AG
- Smiths Medical Inc
- Nipro Corp
- Elcam Medical Group Co
- Merit Medical Systems Inc
- CODAN US Corp
- Nordson Corp
- Cook Medical LLC
- JCM MED SaRL
- Utah Medical Products Inc
North America Advanced Medical Stopcock Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 335.94 Million |
Market Size by 2028 | US$ 430.56 Million |
Global CAGR (2022 - 2028) | 3.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Frequently Asked Questions
What is medical stopcock?
Stopcocks are devices used to direct the flow of fluid through an infusion system while allowing multiple fluids to be connected. Turning an exterior handle allows the clinician to choose the specific fluid or medication to flow at a given time. Stopcocks must meet many requirements of industry standards, such as flow rate, high- or low-pressure resistance, chemical resistance to lipid-based solutions, sterilization compatibility, dead space, and handle-rotating torque.
What are the driving factors for the North America advanced medical stopcock market?
Key factors that are driving the growth of the North America advanced medical stopcock market over years are growing incidence of chronic diseases and surge in number of surgical procedures.
Which type led the market?
The low-pressure stopcocks segment dominated the North America advanced medical stopcock market and held the largest market share of 56.08% in 2021.
Which end user held the largest share in the North America advanced medical stopcock market?
The hospitals & clinics segment dominated the North America advanced medical stopcock market and accounted for the largest revenue share of 51.16% in 2021
Who are the key players in the North America advanced medical stopcock market?
The anal irrigation systems market majorly consists of the players such B. Braun Melsungen AG, Smiths Medical Inc, Nipro Corp, Elcam Medical Group Co, Merit Medical Systems Inc, CODAN US Corp, Nordson Corp, Cook Medical LLC, JCM MED SaRL, Utah Medical Products Inc among others.
What is the market scenario of North America advanced medical stopcock?
North America advanced medical stopcock market is segmented by countries into US, Canada, and Mexico. The US is experiencing rapidly growing prevalence and incidences of chronic conditions such as cancer and infectious diseases. The government of the country is also involved in taking various measures to control the rising prevalence of chronic disorders. The country also spends more on healthcare expenditure that enables to the introduction of various innovative procedures for the treatment of several chronic conditions. Hence, owing to the above-mentioned factors, the growth of US advanced medical stopcock market contributed the largest market share during the forecast period.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















The List of Companies - North America Advanced Medical Stopcock Market
- B. Braun Melsungen AG
- Smiths Medical Inc
- Nipro Corp
- Elcam Medical Group Co
- Merit Medical Systems Inc
- CODAN US Corp
- Nordson Corp
- Cook Medical LLC
- JCM MED SaRL
- Utah Medical Products Inc


